Viking Therapeutics (VKTX) · Previous Close · $ · ; % · Volume: Mil · Volume % Chg: 34% · Get a Leaderboard Chart for VKTX ·? See How IBD. Track Viking Therapeutics Inc (VKTX) Stock Price, Quote, latest community messages, chart, news and other stock related information. VIK | Complete Viking Holdings Ltd. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Looking to buy Viking Therapeutics Stock? View today's VKTX stock price, trade commission-free, and discuss VKTX stock updates with the investor community. Get the latest updates on Viking Therapeutics, Inc. Common Stock (VKTX) pre market trades, share volumes, and more. Make informed investments with Nasdaq.
Research Viking Therapeutics' (Nasdaq:VKTX) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance. VKTX - Viking Therapeutics Inc - Stock screener for investors and traders, financial visualizations. Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends. View Viking Therapeutics, Inc. VKTX stock quote prices, financial information, real-time forecasts, and company news from CNN. The current price of VKTX is USD — it has increased by % in the past 24 hours. Watch Viking Therapeutics, Inc. stock price performance more closely on. Discover real-time Viking Therapeutics, Inc. Common Stock (VKTX) stock prices, quotes, historical data, news, and Insights for informed trading and. Viking Therapeutics is developing novel therapeutics for patients suffering from metabolic and endocrine disorders. Contact. General Information. Viking Therapeutics stock has jumped 10% on Wednesday, currently hovering above $ Market Domination hosts Julie Hyman and Josh Lipton report on the analyst. See the latest Viking Therapeutics Inc stock price (VKTX:XNAS), related news, valuation, dividends and more to help you make your investing decisions. Viking Therapeutics, Inc. (VKTX) reachead $ at the closing of the latest trading day, reflecting a % change compared to its last close.
View today's Viking Therapeutics Inc stock price and latest VKTX news and analysis. Create real-time notifications to follow any changes in the live stock. Viking Therapeutics is developing novel therapeutics for patients suffering from metabolic and endocrine disorders. Contact. General Information. VIK | Complete Viking Holdings Ltd. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Viking Therapeutics (VKTX) has a Smart Score of 9 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom. Company has been rated SELL since 06/29/ The Company's Fundamentals Look Very Poor Making an Investment in Its Shares Purely Speculative. VKTX - Viking Therapeutics, Inc. Stock - Stock Price, Institutional Ownership, Shareholders (NasdaqCM). The average price target is $ with a high forecast of $ and a low forecast of $ The average price target represents a % change from the. Stock Calculator ; Shares on 09/06/ ; Shares Today ; Split Adjustment ; $10, Value on 09/06/ ; $36, Investment Value Today. Get the latest Viking Therapeutics Inc (VKTX) real-time quote, historical performance, charts, and other financial information to help you make more.
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. Key Stats · Market CapB · Shares OutM · 10 Day Average VolumeM · Dividend- · Dividend Yield- · Beta · YTD % Change Viking Thera stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. Viking Therapeutics Stock (NASDAQ: VKTX) stock price, news, charts, stock research, profile. A high-level overview of Viking Therapeutics, Inc. (VKTX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and.
Stock Calculator ; Shares on 09/13/ ; Shares Today ; Split Adjustment ; $10, Value on 09/13/ ; $44, Investment Value Today. See the latest Viking Therapeutics Inc stock price (VKTX:XNAS), related news, valuation, dividends and more to help you make your investing decisions. During the financial year, trading in Viking Line on NASDAQ Helsinki totalled , shares, which corresponds to % of shares. The year's highest share. Get the latest updates on Viking Therapeutics, Inc. Common Stock (VKTX) pre market trades, share volumes, and more. Make informed investments with Nasdaq. Volume, M. Market Value, $B. Shares Outstanding, M. EPS (TTM), -$ P/E Ratio (TTM), N/A. Dividend Yield, N/A. Latest Dividend, N/A. View Viking Therapeutics, Inc. VKTX stock quote prices, financial information, real-time forecasts, and company news from CNN. A high-level overview of Viking Therapeutics, Inc. (VKTX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and. Get the latest Viking Therapeutics Inc (VKTX) real-time quote, historical performance, charts, and other financial information to help you make more. VKTX - Viking Therapeutics Inc - Stock screener for investors and traders, financial visualizations. Company has been rated SELL since 06/29/ The Company's Fundamentals Look Very Poor Making an Investment in Its Shares Purely Speculative. Viking Therapeutics Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. Viking Thera stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. Latest VKTX Press Releases · 08/28/ PM ET. Viking Therapeutics to Participate at Morgan Stanley 22nd Annual Global Healthcare Conference · 08/06/ The 41 analysts offering price forecasts for Viking Therapeutics have a median target of , with a high estimate of and a low estimate of Viking Therapeutics (VKTX) has a Smart Score of 9 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom. Get Viking Holdings Ltd (VIK:NYSE) real-time stock quotes, news, price and financial information from CNBC. Viking Therapeutics Inc (VKTX) stock price, GURU trades, performance, financial stability, valuations, and filing info from GuruFocus. Viking Therapeutics is developing novel therapeutics for patients suffering from metabolic and endocrine disorders. Quote and Chart Stock Data Chart Viking Holdings Ltd New York Stock Exchange: VIK Events. Earnings. Dividends. Splits Price. Price. % Change. $. Stock analysis for Viking Therapeutics Inc (VKTX:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company. VKTX - Viking Therapeutics, Inc. Stock - Share Price, Short Interest, Short Squeeze, Borrow Rates (NasdaqCM). Real-time Price Updates for Viking Thera (VKTX-Q), along with buy or sell indicators, analysis, charts, historical performance, news and more. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends. The average price target is $ with a high forecast of $ and a low forecast of $ The average price target represents a % change from the. Track Viking Therapeutics Inc (VKTX) Stock Price, Quote, latest community messages, chart, news and other stock related information. Viking Therapeutics (VKTX) - Develops novel therapeutics for the treatment of metabolic and endocrine disorders including type 2 diabetes. · SMR Rating · N/A. Complete Viking Therapeutics Inc. stock information by Barron's. View real-time VKTX stock price and news, along with industry-best analysis. Discover real-time Viking Therapeutics, Inc. Common Stock (VKTX) stock prices, quotes, historical data, news, and Insights for informed trading and. Key Stats · Market CapB · Shares OutM · 10 Day Average VolumeM · Dividend- · Dividend Yield- · Beta · YTD % Change
Given the current short-term trend, the stock is expected to rise % during the next 3 months and, with a 90% probability hold a price between $ and. Viking Therapeutics, Inc. (ye-ti.ru): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Viking Therapeutics. On average, Wall Street analysts predict that Viking Therapeutics's share price could reach $ by Sep 12, The average Viking Therapeutics stock price. Get the latest Viking Therapeutics Inc. (VKTX) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals. Research Viking Therapeutics' (Nasdaq:VKTX) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance.